U.S to allots 85% less Johnson & Johnson COVID-19 vaccines
The U.S government will allots nearly 85% less Johnson & Johnson COVID-19 vaccines to states next week.
According to data from Centers for Disease Control and Prevention (CDC), Only 785,500 J&J doses will be allocated, compared to 4.95 million doses this week.
The U.S. Department of Health and Human Services (HHS) and J&J did not immediately respond to requests made outside regular hours, for comment on the drop in numbers.
In a report last week, showed that workers at an Emergent BioSolutions facility in Baltimore, which produced both AstraZeneca Plc and J&J doses, mixed up ingredients of the two vaccines, ruining 15 million J&J doses.
However, the Baltimore facility has not yet been authorized by the U.S. Food and Drug Administration and none of the vaccine doses from the plant have been used in vaccination efforts so far.
Johnson & Johnson has reiterated that it expected to deliver 100 million doses to the government by the end of May.